Search results for: Health Policy and Regulation
Filter search results
Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies
1 April 2017
…Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special… The 2016 meeting of the HTAi Asia Policy Forum meeting was held in Kuala Lumpur, 17th -18th…
Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Therapies
8 January 2020
…alterations of cancer cells rather than tissue of origin, face significant methodological and policy hurdles related to evidence development and acceptance, value assessment and reimbursement pathways, and diagnostic infrastructure availability….
The R&D Cost of a New Medicine
1 December 2012
…and the cost of capital. It also discusses measures companies are taking now to improve efficiency and offers a glimpse into the promise and challenges presented by the new, gene-based…
Pharmaceutical Research: the Case for Growth in Britain
1 July 1967
…encouragement for the pharmaceutical industry to expand its research. This, in turn, may have arisen from a failure to understand the economics of innovation in research-based companies. Seen in the…
Antibiotics in Animal Husbandry
1 July 1969
…economic benefits these yielded. Almost at once, however, the work of Dr E.S. Anderson and others focussed attention on the potential hazards of antibiotic resistance spreading from animals to man….
Exploring the Interdependencies of Research Funders in the UK
1 July 2014
…and can be downloaded from: https://link.springer.com/article/10.1186%2Fs12961-015-0027-6 Please cite as: Shah, K., Sussex, J. and Hernandez-Villafuerte, K., 2015. Government and charity funding of cancer research: public preferences and choices. Health Research…
Don’t Look Back? Voluntary and Charitable Finance of Hospitals
1 July 2001
…the state and funded initially by charitable gifts, these hospitals cared for the acute sick before 1948 and were the centres of research and teaching. We discuss their performance, and…
Incentives for R&D for New Antimicrobial Drugs
1 April 2011
Antimicrobial resistance (AMR) is becoming a major global public health threat and has begun to command attention from European and US policy makers. An initial focus on monitoring AMR and…